Amerisource Health Services Glimepiride Tablets, USP, 2 mg, RX, Packaged as a ) 100-count recall — FDA D-0758-2023
CGMP Deviations: recalling drug products following an FDA inspection.
Browse the newest complete recall records currently stored from FDA enforcement reports and NHTSA vehicle campaigns. “Latest” refers to the newest source-dated record in this database, not the timestamp of our last API check.
The newest recall records with useful source details are listed here.
CGMP Deviations: recalling drug products following an FDA inspection.
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Failed Impurities/Degradation Specifications: firm's investigation due to customer complaints for discoloration found that the product was out of specification for an impurity.
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Browse recent months with enough recall history for useful comparison.